GLP-1s do not work for everyone: why and what should you do?
admin GLP-1 receptor agonists have gained favor in recent years for treating type 2 diabetes as well as weight loss. According to recent polls, approximately one in every eight persons in…
Can 36 minutes of properly tuned music ‘reset’ an anxious brain?
Many individuals nowadays choose to listen to pink noise, which is a background sound comparable to rain or static, to unwind, fall asleep, or drown out annoying sounds like traffic…
Tackling stem-like cells may minimize the probability of colorectal cancer returning
Colorectal cancer is the third most frequent type of cancer worldwide, but it is also the second biggest cause of cancer-related fatalities. Growing study reveals the influence of colorectal cancer…
GLP-1 may not cause as much muscle loss as some experts thought
The usage of GLP-1 receptor agonists for weight loss, such as Zepbound and Wegovy, is increasing. According to recent polls, one out of every eight Americans is currently using a…
WHO Member States agree to continue negotiations on the Pathogen Access and Benefit Sharing Annex
Member States of the World Health Organization (WHO) have made progress on the Pathogen Access and Benefit Sharing (PABS) annex, a key component of the WHO Pandemic Agreement, and today…